NEXTBio Capital Management’s BlossomHill Therapeutics BLSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.66M Buy
+250,000
New +$4.97M 1.99% 20

Other funds holding BLSM

NEXTBio Capital Management's BLSM Position: Q3 2026 in Review

NEXTBio Capital Management opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 250,000 shares worth $4.66M. The stake represents 1.99% of the portfolio and ranks #20 among its holdings.

39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.

  • NEXTBio Capital Management held 250,000 shares of BlossomHill Therapeutics worth $4.66M as of Q3 2026.
  • BlossomHill Therapeutics was a new NEXTBio Capital Management position in Q3 2026.
  • BlossomHill Therapeutics made up 1.99% of NEXTBio Capital Management's portfolio in Q3 2026, its #20 holding.
  • 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.

Based on NEXTBio Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.